Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,452,000 (effective 2022-11-18).
“On November 18, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 3,541,469 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.41 per share, in exchange for aggregate consideration of $1,452,000.”
James Klein was appointed as director at Streamex Corp..
“On May 2, 2022, James Klein was appointed to the Board, effective as of the same date, to fill the vacancy on the Board as a result of Mr. Navarro’s resignation”
Samuel E. Navarro resigned as director at Streamex Corp..
“On April 28, 2022, Samuel E. Navarro resigned from the board of directors (the “ Board ”) of BioSig Technologies, Inc.”
Frederick Hrkac was appointed as director at Streamex Corp..
“On April 28, 2022, Frederick Hrkac was appointed to the Board, effective as of the same date, to fill the vacancy on the Board as a result of Mr. Zook’s resignation”
Anthony Zook resigned as director at Streamex Corp..
“On April 22, 2022, Anthony Zook resigned from the board of directors (the “ Board ”) of BioSig Technologies, Inc. (the “ Company ”).”
John Sieckhaus was appointed as Chief Operating Officer at Streamex Corp..
“On March 16, 2022, the Board of Directors (the “ Board ”) of BioSig Technologies, Inc. (the “ Company ”) appointed Mr. John Sieckhaus as the Chief Operating Officer of the Company, whose employment commenced on March 21, 2022.”
James J. Barry was appointed as director at Streamex Corp..
“On September 20, 2021, the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) appointed James J. Barry, Ph.D. as a director of the Company, effective as of the same date”
Jeffrey F. O’Donnell, Sr. resigned as Director at Streamex Corp..
“On June 30, 2021, Jeffrey F. O’Donnell, Sr. tendered his resignation from the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”), effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.